From the Journals

Heart health in pregnancy tied to CV risk in adolescent offspring


 

Mother-child pairs

Dr. Perak and colleagues used data from the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study and the HAPO Follow-up Study.

Participants were 2,302 mother-child pairs from nine field centers in Barbados, Canada, China, Thailand, United Kingdom, and the United States, and represented a racially and ethnically diverse cohort.

The mean ages were 29.6 years for pregnant mothers and 11.3 years for children. The pregnancies occurred between 2000 and 2006, and the children were examined from 2013 to 2016, when the children were aged 10-14 years.

Using the American Heart Association’s definition of cardiovascular health, the scientists categorized pregnancy health for mothers based on their measures of body mass index, blood pressure, total cholesterol, glucose level, and smoking status at 28 weeks’ gestation. These five metrics of gestational cardiovascular health have been significantly associated with adverse pregnancy outcomes.

They categorized cardiovascular health for offspring at age 10-14 years based on four of these five metrics: body mass index, blood pressure, cholesterol, and glucose.

Only 32.8% of mothers and 42.2% of children had ideal cardiovascular health.

In analyses adjusted for pregnancy and birth outcomes, the associations seen between poor gestational maternal health and offspring cardiovascular health persisted but were attenuated.

Dr. Perak reported receiving grants from the Woman’s Board of Northwestern Memorial Hospital; the Dixon Family; the American Heart Association; and the National Heart, Lung, and Blood Institute. Dr. Daniels reported no conflicts of interest.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Experts disagree with USPSTF’s take on pediatric blood pressure screening
MDedge Cardiology
COVID-19 cases in children continue to set records
MDedge Cardiology
Metformin improves most outcomes for T2D during pregnancy
MDedge Cardiology
Obesity, hypoxia predict severity in children with COVID-19
MDedge Cardiology
Infant’s COVID-19–related myocardial injury reversed
MDedge Cardiology
New dietary guidelines omit recommended cuts to sugar, alcohol intake
MDedge Cardiology
Tofacitinib for RA misses the mark in safety study
MDedge Cardiology
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
MDedge Cardiology
Teenagers get in the queue for COVID-19 vaccines
MDedge Cardiology
Steroid and immunoglobulin standard of care for MIS-C
MDedge Cardiology